The Use of Sildenafil and the Risk of Sexually Transmitted Diseases, Risky Sexual Behavior, and HIV Infection Reviewed
Friday, 24 June 2005
BERKELEY, CA (UroToday Inc.) - Since the arrival of sildenafil (Viagra®) for the treatment of male sexual dysfunction to the marketplace on March, 27, 1998, an estimated 16 million men worldwide have tried the drug.
read more
|
Efficacy Greater Than 80% Seen In Avanafil Erectile Dysfunction Clinical Trial
Thursday, 23 June 2005
VIVUS, Inc. today announced positive results from a Phase 2 study to evaluate the effects of avanafil, its next-generation, fast-acting, highly selective, investigational oral phosphodiesterase type 5 (PDE5) inhibitor, in men with erectile dysfunction (ED).
read more
|
Sterility Following Vasectomy May Take Time
Thursday, 09 June 2005
NEW YORK (Reuters Health) - Following vasectomy, more than half of men who initially show motile sperm go on to demonstrate azoospermia, Canadian researchers report in the May issue of Fertility and Sterility.
read more
|
Testosterone Plus PDE Inhibitor Improves Erectile Dysfunction in Elderly Men
Thursday, 09 June 2005
NEW YORK (Reuters Health) - In healthy aging men with erectile dysfunction (ED), low dose testosterone therapy added to low-dose phosphodiesterase 5 (PDE-5) inhibitor therapy significantly improves erectile function and quality of life, according to research presented this week at ENDO 2005, the 87th annual meeting of The Endocrine Society.
read more
|
Men with Cystic Fibrosis Want More Information Regarding Sexual and Reproductive Health
Monday, 06 June 2005
BERKELEY, CA (UroToday Inc.) - Cystic fibrosis (CF) can lead to urologic issues regarding infertility as well as the expected pulmonary issues that may require transplantation.
read more
|
Erectile Dysfunction After Brachytherapy Reaches 50 Percent After 3 Years
Friday, 03 June 2005
BERKELEY, CA (UroToday Inc.) - Few prospective trials have evaluated the incidence of erectile dysfunction after brachytherapy using validated quality of life questionnaires.
read more
|
Sildenafil Useful for Erectile Dysfunction in Men with Multiple Sclerosis
Tuesday, 31 May 2005
NEW YORK (Reuters Health) - Erectile dysfunction is a common problem for men with multiple sclerosis and now new research indicates that sildenafil is an effective and well-tolerated treatment for erectile difficulties in such patients.
read more
|
Type of Blindness Reported in Some Taking Viagra
Tuesday, 31 May 2005
WASHINGTON (Reuters) - U.S. health regulators said on Friday they have received more than 40 reports of a type of blindness in men taking impotence drugs, mostly involving Pfizer Inc.'s Viagra, but have not determined if the medicines were responsible.
read more
|
Dapoxetine Effective for Premature Ejaculation
Monday, 23 May 2005
NEW YORK (Reuters Health) - A new drug called dapoxetine appears to be a safe and effective treatment for premature ejaculation, a problem not specifically addressed by current medications, according to findings presented Monday at the annual meeting of the American Urological Association in San Antonio.
read more
|
The Effects of Schizophrenic Medications on Male Sexual Dysfunction and Quality of Life
Wednesday, 11 May 2005
BERKELEY, CA (UroToday Inc.) - Sexual dysfunction often goes unrecognized in adult schizophrenic patients, but reportedly affects up to 60% of these individuals.
read more
|
Femoral Nailing Tied to High Rate of Erectile Dysfunction in Young Men
Monday, 02 May 2005
NEW YORK (Reuters Health) - About 40% of sexually active men who undergo intramedullary nailing for a femoral shaft fracture report erectile dysfunction (ED), according to a recent report by French researchers. Intraoperative use of muscle relaxants appears to cut the risk of dysfunction.
read more
|
Review Renders Details about Etiology and Incidence of Erectile Dysfunction after Pelvic Fracture
Friday, 29 April 2005
BERKELEY, CA (UroToday Inc.) - Male sexual dysfunction after fracture of the pelvis is more common than previously supposed, with rates as high as 30% reported when the complaint is specifically sought.
read more
|
Treatment with Alfuzosin 10 mg per Day Improves Existing Erectile and Ejaculatory Dysfunction in Men with LUTS
Wednesday, 20 April 2005
BERKELEY, CA (UroToday Inc.) - Van Mooselaar and colleagues from the ALF-ONE Study group assessed the effect of alfuzosin 10mg on sexual function in patients with lower urinary tract symptoms (LUTS) consistent with bladder outlet obstruction (BOO).
read more
|
Hypogonadism does Not Impact Quality of Life in Older Men with COPD
Monday, 18 April 2005
NEW YORK (Reuters Health) - Free testosterone level has no apparent relationship with quality of life, respiratory symptoms or physical activity among older men with COPD, a new study shows.
read more
|
Alfuzosin Improves Sexual Function in Men with Lower Urinary Tract Symptoms
Monday, 21 March 2005
NEW YORK (Reuters Health) - The uroselective alpha-1-blocker alfuzosin relieves symptoms of sexual dysfunction that are common among men with lower urinary tract symptoms (LUTS), a multinational team reports in the March issue of BJU International.
read more
|
Erectile Dysfunction (ED) 
